Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt
Arcaion / Pixabay

Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt

According to a story from wtvbam.com, the drug development company Alnylam Pharmaceuticals has recently stated that it is looking less likely that its gene silencing therapy givosiran will be getting…

Continue Reading Despite Effectiveness, Accelerated Approval For Acute Hepatic Porphyria Drug in Doubt
Ultragenyx has Released Updates on Their Study of a Potential Gene Therapy for OTC Deficiency
mcmurryjulie / Pixabay

Ultragenyx has Released Updates on Their Study of a Potential Gene Therapy for OTC Deficiency

Ultragenyx Pharmaceuticals has shared data from two cohorts taking part in an on-going study involving an investigational gene therapy for ornithine transcarbamylase deficiency. For more information, you can view the…

Continue Reading Ultragenyx has Released Updates on Their Study of a Potential Gene Therapy for OTC Deficiency
Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
source: pixabay.com

Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria

Topline results have been shared from a Phase 3 study of the investigational drug givosiran in patients with acute hepatic porphyria. For more detailed information you can view the source…

Continue Reading Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
An Honest Interview on Living with Cystinosis, Kidney Transplants, and Cancer
Lyme is contracted by ticks, which means nature and hiking-lovers are at a higher risk.

An Honest Interview on Living with Cystinosis, Kidney Transplants, and Cancer

Many persons living with rare disease require a transplant of certain organs. Though this is not a cure for the rare disease Cystinosis, a kidney transplant is often required once the disease…

Continue Reading An Honest Interview on Living with Cystinosis, Kidney Transplants, and Cancer
Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research
Kapa65 / Pixabay

Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research

According to a story from Parkinson's News Today, a recent analysis of Parkinson's disease research showed that scientists would benefit from relying less on animal models and instead should focus…

Continue Reading Recent Study Recommends Steering Away From Animal Models For Parkinson’s Disease Research
New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
blickpixel / Pixabay

New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy

Researchers at the University of Utah are working on developing computational tools that can be used to help identify the genetic changes underlying early infantile epileptic encephalopathy. For more detailed…

Continue Reading New Tools are Being Developed to Help Understand the Genetic Causes of Early Infantile Epileptic Encephalopathy
Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
geralt / Pixabay

Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements

Shriners Hospitals for Children® has announced their motion analysis centre consortium. The hospital’s Motion Analysis Centre is used to evaluate the movements and gait of children and teenagers. To read about…

Continue Reading Shriners Hospitals for Children® are Using Motion Analysis Centres to Help Understand Patients’ Movements
A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
Alexas_Fotos / Pixabay

A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria

According to a story from Medical Xpress, an international group of scientists from the US, France, and Spain may have discovered that an antifungal agent commonly used to treat skin…

Continue Reading A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation
qimono / Pixabay

The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation

The United States Food and Drug Administration has awarded Orphan Drug Designation to an experimental PLX cell therapy (called PLX-R18) as a treatment for graft failure and incomplete haematopoietic recovery…

Continue Reading The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation

Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases

According to a story from UPI, gene editing technology could be a potential treatment for mitochondrial diseases, a rare, genetic illness that is usually fatal. In a proof-of-concept experiment, researchers…

Continue Reading Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases
Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Free-Photos / Pixabay

Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials

According to a story from Angioedema News, an investigational product from BioCryst Pharmaceuticals called BCX7353 was able to quickly subdue swelling attacks in hereditary angioedema in clinical trials. In addition,…

Continue Reading Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation
PDPics / Pixabay

Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation

According to a story from globenewswire.com, the pharmaceutical company Portola Pharmaceuticals recently announced that its investigational product cerdulatinib has earned Orphan Drug designation from the US Food and Drug Administration…

Continue Reading Experimental Treatment for Peripheral T-Cell Lymphoma Gets Orphan Drug Designation

A Boy With Congenital Muscular Dystrophy is Being Supported in a Special Way

Michael Dickerson, aged 42, is originally from Hoedspruit Limpopo, South Africa. Recently, Michael was participating in a series of long distance trail runs when he learned about the story of Daniël…

Continue Reading A Boy With Congenital Muscular Dystrophy is Being Supported in a Special Way
ICYMI: After Rejection, The Familial Chylomicronemia Foundation Urges The FDA to Consider Approving New Treatment
www_slon_pics / Pixabay

ICYMI: After Rejection, The Familial Chylomicronemia Foundation Urges The FDA to Consider Approving New Treatment

According to a story from BioSpace, the U.S. Food and Drug Administration (FDA) recently rejected the approval of the drug Waylivra, which was in development for the treatment of familial…

Continue Reading ICYMI: After Rejection, The Familial Chylomicronemia Foundation Urges The FDA to Consider Approving New Treatment